Tuesday, July 28, 2026

South Korean President’s Approval Rating at 34% for the Second Week in a Row

President Yoon Seok Yeol's job performance approval...

7 Years Later: Is the 9/19 Military Agreement on the Brink of Collapse?

The 9·19 military agreement, signed in 2018 under the watch of North and South Korean leaders, marks its 7th anniversary but has stalled.

Han Kang Faces Global Press for the First Time After Winning Nobel Prize in Literature

Han Kang, the first Asian female Nobel laureate, held her first global press conference discussing her works and recent political events.

Tag: ADCs

Unlocking Cancer Treatment: ABL206 and ABL209’s Promising Non-Clinical Data Revealed at AACR

ABL Bio will present preclinical data for its ADCs ABL206 and ABL209 at AACR 2023, showcasing promising anti-cancer efficacy.

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

Top News

- Our Sponsors Ad -

Follow us